Anthera Pharmaceuticals Inc $1.84

up +0.17


23/9/2014 04:00 PM  |  NASDAQ : ANTH  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get ANTH Trend Analysis - it has underperformed the S&P 500 by 76%

Partner Headlines

  1. Stocks Hitting 52-Week Lows

    Benzinga
  2. Benzinga's Top #PreMarket Gainers

    Benzinga
  3. Anthera Pharmaceuticals Announces Acquisition of Sollpura For Exocrine ...

    Benzinga
  4. Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce ...

    Benzinga
  5. Anthera Pharmaceuticals Accused of Withholding Data

    Benzinga
  6. Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  7. Benzinga's Microcap Movers for Monday September 17, 2012

    Benzinga
  8. Benzinga's Microcap Movers for Friday August 24, 2012

    Benzinga
  9. Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  10. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common ...

    Benzinga
  11. Benzinga's Microcap Movers for Wednesday July 18, 2012

    Benzinga
  12. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock; ...

    Benzinga
  13. Benzinga's Microcap Movers for Tuesday July 17, 2012

    Benzinga
  14. Benzinga's Microcap Movers for Monday July 16, 2012

    Benzinga
  15. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed ...

    Benzinga
  16. Anthera Pharmaceuticals Inc. (ANTH) CEO Paul F Truex buys 20,000 Shares

    GuruFocus
  17. ProShares Trust Ultra VIX Short Term Futures ETF, Nokia Corporation Among ...

    FoxBusiness
  18. Health Care Sector Wrap

    FoxBusiness
  19. Anthera Pharmaceuticals Down 65% After Reporting Phase 2b PEARL-SC Clinical ...

    Benzinga
  20. Benzinga's Top Downgrades

    Benzinga
  21. Anthera Updates Phase 3 Plans

    Benzinga
  22. Benzinga's Microcap Movers for Friday June 15, 2012

    Benzinga
  23. Stock Futures Little Changed Ahead of Data with Morgan Stanley (MS) and ...

    MarketIntelligenceCenter
  24. UPDATE: Summer Street Research Partners Initiates Buy, $15 PT on Anthera ...

    Benzinga
  25. Morning Social Media Outlook for Wednesday Feb 22

    Benzinga
  26. Anthera Pharmaceuticals Inc. (ANTH) President and CEO Paul F Truex sells ...

    GuruFocus
  27. Anthera Announces Completion of Safety Review by DSMB for VISTA-16

    Benzinga
  28. UPDATE: Canaccord Initiates Buy, $13 Target on Anthera Pharmaceuticals

    Benzinga
  29. Canaccord Initiates Anthera Pharmaceuticals at Buy, $13 PT

    Benzinga
Trading Center